Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1775-1789
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 17
Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 2
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 32
The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2469-2480
Closed Access | Times Cited: 26
Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 25
Depression and type 2 diabetes: A causal relationship and mechanistic pathway
Wael Y. Khawagi, Hayder M. Al‐kuraishy, Nawar R. Hussein, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3031-3044
Open Access | Times Cited: 12
Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7092-7108
Open Access | Times Cited: 11
N-acetylcysteine Protects Against Myocardial Ischemia–Reperfusion Injury Through Anti-ferroptosis in Type 1 Diabetic Mice
Dongcheng Zhou, Yuhui Yang, Jiajia Chen, et al.
Cardiovascular Toxicology (2024) Vol. 24, Iss. 5, pp. 481-498
Open Access | Times Cited: 11
The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon
Hayder M. Al‐kuraishy, Sadiq M. Al‐Hamash, Majid S. Jabir, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102200-102200
Closed Access | Times Cited: 10
Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors
Min Qiao, Junjun Ni, Hong Qing, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102075-102075
Closed Access | Times Cited: 21
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 7
Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 3, pp. 639-649
Open Access | Times Cited: 7
Cyclin‐dependent kinase 5 (CDK5) inhibitors in Parkinson disease
Mohammed Alrouji, Haydar M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 5
uN2CpolyG-mediated p65 nuclear sequestration suppresses the NF-κB-NLRP3 pathway in neuronal intranuclear inclusion disease
Yu Shen, Kaiyan Jiang, Dandan Tan, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Regulation of Postoperative Cognitive Dysfunction by Glutathione Under Various Pathways: A Narrative Review
Yan He, Ying Zhang, Qing Liu
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Adaptive feature selection with flexible mapping for diagnosis and prediction of Parkinson's disease
Zhongwei Huang, Jianqiang Li, Jiatao Yang, et al.
Engineering Applications of Artificial Intelligence (2025) Vol. 146, pp. 110342-110342
Closed Access
Targeting NLRP3 and AIM2 signaling pathways by Viscosol alleviates metabolic dysregulations induced inflammatory responses in diabetic neuro- and nephropathy: An in silico and in vivo study
Summan Thahiem, Muhammad Ihsan, Hamza Muneer, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0313816-e0313816
Open Access
Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111349-111349
Open Access
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
The Neuroprotective Effects of Agmatine on Parkinson’s Disease: Focus on Oxidative Stress, Inflammation and Molecular Mechanisms
Mohammad Yasin Zamanian, Mozhgan Nazifi, Lusine Khachatryan, et al.
Inflammation (2024)
Closed Access | Times Cited: 3
Calpeptin improves the cognitive function in Alzheimer's disease‐like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome
Luyao Qiao, Shouqin Yi, Tianpei Li, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 10, pp. 1365-1376
Open Access | Times Cited: 2
The neuroprotective effect of vitamin D in Parkinson's disease: association or causation
Amin A. Hafiz
Nutritional Neuroscience (2023) Vol. 27, Iss. 8, pp. 870-886
Closed Access | Times Cited: 6
Integrated network pharmacology and phosphoproteomic analyses of Baichanting in Parkinson's disease model mice
Xin Gao, Jiaqi Fu, Donghua Yu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e26916-e26916
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top